ESC 365 - Oral anticoagulant monotherapy vs oral anticoagulant/antiplatelet therapy for the management of atrial fibrillation and stable coronary artery disease

EAPC Premium Access

Oral anticoagulant monotherapy vs oral anticoagulant/antiplatelet therapy for the management of atrial fibrillation and stable coronary artery disease

Session: Moderated abstracts - Primary Care and Risk Factor Management

Topic: Clinical

Speaker: Ms A. Abdul Razzack (Vijayawada, IN)

Event: ESC Preventive Cardiology 2021

Congress Presentation

Add to my library

About the speaker

Ms Aminah Abdul Razzack

Larkin Community Hospital Inc, Vijayawada (India)

0 follower

3 more presentations in this session

Aging is accompanied by a decrease in the number of naive Tregs.

Speaker: Miss A. Filatova (Moscow, RU)

Cardiac biomarkers for cardiovascular risk prediction among women and men from the general population

Speaker: Miss F. Zhu (Rotterdam, NL)

Improvement of cardiovascular risk prediction by longitudinal risk factor and competing risk data

Speaker: Doctor I. Roman Degano (Barcelona, ES)

Access the full session

Moderated abstracts - Primary Care and Risk Factor Management

Speakers: Ms A. Abdul Razzack, Miss A. Filatova, Miss F. Zhu, Doctor I. Roman Degano

About the event

ESC Preventive Cardiology 2021

15 April - 17 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources